The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Human Vaccines & Immunotherapeutics
(Mar 2021)
Cost-effectiveness analysis has to consider all available evidence when informing inputs
Fabián P. Alvarez,
Audrey Petitjean,
Joshua Nealon,
Rosalind Hollingsworth,
Juan Luis López-Belmonte
Affiliations
Fabián P. Alvarez
Sanofi Pasteur
Audrey Petitjean
Sanofi Pasteur
Joshua Nealon
Sanofi Pasteur
Rosalind Hollingsworth
Sanofi Pasteur
Juan Luis López-Belmonte
Sanofi Pasteur
DOI
https://doi.org/10.1080/21645515.2020.1799670
Journal volume & issue
Vol. 17, no. 3
pp. 694 – 695
Abstract
Read online
No abstracts available.
Keywords
influenza
vaccination
spain
quadrivalent influenza vaccine (qiv)
cost-effectiveness
cell-based vaccines
egg-based vaccines
WeChat QR code
Close